Top Markets
Coin of the day
Broncus Holding Corporation Broncus Holding Corporation

Broncus Holding Corporation

2216
Pozycja w akcjach #26180
Broncus Holding Corporation is a global medical technology company specializing... Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.
Cena akcji
$0.08123316
Kapitalizacja rynkowa
$42.78M
Zmiana (1 dzień)
4.96%
Zmiana (1 rok)
-79.73%
Kraj
CN
Handel Broncus Holding Corporation (2216)

Kategoria

Cena 2216 z kapitalizacją rynkową B
Broncus Holding Corporation Broncus Holding Corporation
2216
$0.08123316
Kapitalizacja rynkowa Broncus Holding Corporation(2216)
Kapitalizacja rynkowa: $42.78M
Na dzień August 2026 spółka Broncus Holding Corporation ma kapitalizację rynkową wynoszącą $42.78M. Według naszych danych, czyni to Broncus Holding Corporation 26180th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Broncus Holding Corporation od 2021 do 2026
2216 w porównaniu do 5 najpopularniejszych stocks
Cena za 2216 Aktywa B Kapitalizacja rynkowa B Wyniki
Broncus Holding Corporation Broncus Holding Corporation
$9,975.62 $42.78M
$5.253T +12,280,133.75%
Broncus Holding Corporation Broncus Holding Corporation
$8,846.65 $42.78M
$4.658T +10,890,344.92%
Broncus Holding Corporation Broncus Holding Corporation
$7,787.94 $42.78M
$4.101T +9,587,039.41%
Broncus Holding Corporation Broncus Holding Corporation
$6,819.41 $42.78M
$3.591T +8,394,760.78%
Broncus Holding Corporation Broncus Holding Corporation
$5,376.52 $42.78M
$2.831T +6,618,523.29%